Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

These are direct-prediction models trained from scratch on small, heavily augmented datasets—not few-shot prompting. ARC remains the canonical target; broader leaderboard context and rules (e.g., ...

Abstract: Recursive identification for semiparametric multi-channel Wiener systems is considered in the paper. Based on stochastic approximation, the recursive estimates are given for coefficients of ...

in Oracle a recursive CTE unfortunately cannot be marked with the recursive keyword (despite the ANSI standard) and in Postgres it must be marked with "recursive". In Oracle a CTE is inherently ...

Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7) SALT LAKE CITY, Aug. 05, 2025 ...

Abstract: This paper proposes an optimized image segmentation technology based on recursive feature aggregation convolution (RFAConv) and YOLOv11, which solves the traditional algorithm and can ...

Shares of Recursion Pharmaceuticals (NASDAQ:RXRX) traded higher in the premarket on Tuesday after the AI-driven biotech announced plans to reduce its workforce by approximately 20% as part of a ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion said it will end development for four of its 11 pipeline programs—one of which the company will consider outlicensing to a partner instead—and pause a fifth program, in a pruning designed to ...